Loading…
Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions
Purpose Magnetic Occult Lesion Localization Instrument (MOLLI) is a wireless, non-radioactive alternative for non-palpable breast lesion localization. The primary objective of this first-in-human study was to evaluate the clinical feasibility of using MOLLI for intraoperative localization of non-pal...
Saved in:
Published in: | Breast cancer research and treatment 2020-02, Vol.179 (3), p.671-676 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c541t-8886af3ffe5d050f94d7d801c580c1a2f79de8a9f992f6f0c86234c099ef01233 |
---|---|
cites | cdi_FETCH-LOGICAL-c541t-8886af3ffe5d050f94d7d801c580c1a2f79de8a9f992f6f0c86234c099ef01233 |
container_end_page | 676 |
container_issue | 3 |
container_start_page | 671 |
container_title | Breast cancer research and treatment |
container_volume | 179 |
creator | Look Hong, Nicole Wright, Frances C. Semple, Mark Nicolae, Alexandru M. Ravi, Ananth |
description | Purpose
Magnetic Occult Lesion Localization Instrument (MOLLI) is a wireless, non-radioactive alternative for non-palpable breast lesion localization. The primary objective of this first-in-human study was to evaluate the clinical feasibility of using MOLLI for intraoperative localization of non-palpable breast lesions.
Methods
Twenty women with non-palpable breast lesions at a single institution received a lumpectomy using the MOLLI guidance system. Patients were co-localized with magnetic and radioactive markers up to 7 days before excision by a dedicated breast radiologist under sonographic guidance. Both markers were localized intraoperatively using dedicated hand-held probes. The primary outcome was successful excision of the magnetic marker, confirmed radiographically and pathologically. Demographic data, margin positivity, and re-excision rates were collected. Surgical oncologists, radiologists, and pathology staff were surveyed for user satisfaction.
Results
Post-radiological analysis:
Post-implant mammograms verified that 17/20 markers were placed directly in the lesion center. Radiologists reported that all marker implantations procedures were “easy” or “very easy” following a single training session.
Post-surgical analysis:
All MOLLI markers were successfully removed with the specimen during surgical excision. In all cases, surgeons ranked the MOLLI guidance system as “very easy” for lesion localization.
Pathologic analysis:
All patients had negative margins. All anatomic pathology staff ranked the MOLLI system as “very easy” to localize markers.
Conclusions
The MOLLI guidance system is a reliable and accurate method for intraoperative localization of non-palpable breast lesions. Further evaluation of the MOLLI system in studies against current standards of care is required to demonstrate system cost-effectiveness and improved patient-reported outcomes. |
doi_str_mv | 10.1007/s10549-019-05499-z |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6997262</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A613163945</galeid><sourcerecordid>A613163945</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-8886af3ffe5d050f94d7d801c580c1a2f79de8a9f992f6f0c86234c099ef01233</originalsourceid><addsrcrecordid>eNp9kt9qFDEUxgdR7Lr6Al5IwJsKTj2Zf5ncCKVYXZiyIHodspmTbUomWZOZYvdRfNpmd2trRSQMycz5fd-ZE74se03hhAKwD5FCXfEcaHrSgefbJ9mM1qzMWUHZ02wGtGF500JzlL2I8QoAOAP-PDsqKUuCms6yX18xTnaMxGsiyeZSRiSL98R5lwfpej-YLfYkjlN_Q_Ba2kmOxq0TeiHXDkejyFKpZEA6jMY70nklrdkmKr0sXBzDNKAbyfHFsusW74j2geBPZfZw6rlrtJF2I1cWySqgjCOxe6v4MnumpY346m6fZ9_PP307-5J3y8-Ls9MuV3VFx7xt20bqUmuse6hB86pnfQtU1S0oKgvNeI-t5JrzQjcaVNsUZaWAc9RAi7KcZx8PvptpNWCv0u8GacUmmEGGG-GlEY8rzlyKtb8WDeesSGbz7PjOIPgfE8ZRDCYqtFY69FMUxe66eQlsh779C73yU3BpvETVUBRQAX-g1tKiME771FftTMVpQ0valLyqE3XyDyqtHgejvENt0vdHguIgUMHHGFDfz0hB7BIlDokSKVFinyixTaI3f97OveR3hBJQHoCYSm6N4WGk_9jeApln2DE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2350220409</pqid></control><display><type>article</type><title>Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions</title><source>Springer Link</source><creator>Look Hong, Nicole ; Wright, Frances C. ; Semple, Mark ; Nicolae, Alexandru M. ; Ravi, Ananth</creator><creatorcontrib>Look Hong, Nicole ; Wright, Frances C. ; Semple, Mark ; Nicolae, Alexandru M. ; Ravi, Ananth</creatorcontrib><description>Purpose
Magnetic Occult Lesion Localization Instrument (MOLLI) is a wireless, non-radioactive alternative for non-palpable breast lesion localization. The primary objective of this first-in-human study was to evaluate the clinical feasibility of using MOLLI for intraoperative localization of non-palpable breast lesions.
Methods
Twenty women with non-palpable breast lesions at a single institution received a lumpectomy using the MOLLI guidance system. Patients were co-localized with magnetic and radioactive markers up to 7 days before excision by a dedicated breast radiologist under sonographic guidance. Both markers were localized intraoperatively using dedicated hand-held probes. The primary outcome was successful excision of the magnetic marker, confirmed radiographically and pathologically. Demographic data, margin positivity, and re-excision rates were collected. Surgical oncologists, radiologists, and pathology staff were surveyed for user satisfaction.
Results
Post-radiological analysis:
Post-implant mammograms verified that 17/20 markers were placed directly in the lesion center. Radiologists reported that all marker implantations procedures were “easy” or “very easy” following a single training session.
Post-surgical analysis:
All MOLLI markers were successfully removed with the specimen during surgical excision. In all cases, surgeons ranked the MOLLI guidance system as “very easy” for lesion localization.
Pathologic analysis:
All patients had negative margins. All anatomic pathology staff ranked the MOLLI system as “very easy” to localize markers.
Conclusions
The MOLLI guidance system is a reliable and accurate method for intraoperative localization of non-palpable breast lesions. Further evaluation of the MOLLI system in studies against current standards of care is required to demonstrate system cost-effectiveness and improved patient-reported outcomes.</description><identifier>ISSN: 0167-6806</identifier><identifier>EISSN: 1573-7217</identifier><identifier>DOI: 10.1007/s10549-019-05499-z</identifier><identifier>PMID: 31754951</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Breast ; Breast cancer ; Cancer research ; Clinical Trial ; Lesions ; Localization ; Lumpectomy ; Medicine ; Medicine & Public Health ; Oncology</subject><ispartof>Breast cancer research and treatment, 2020-02, Vol.179 (3), p.671-676</ispartof><rights>The Author(s) 2019</rights><rights>COPYRIGHT 2020 Springer</rights><rights>Breast Cancer Research and Treatment is a copyright of Springer, (2019). All Rights Reserved. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-8886af3ffe5d050f94d7d801c580c1a2f79de8a9f992f6f0c86234c099ef01233</citedby><cites>FETCH-LOGICAL-c541t-8886af3ffe5d050f94d7d801c580c1a2f79de8a9f992f6f0c86234c099ef01233</cites><orcidid>0000-0003-4583-5741</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31754951$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Look Hong, Nicole</creatorcontrib><creatorcontrib>Wright, Frances C.</creatorcontrib><creatorcontrib>Semple, Mark</creatorcontrib><creatorcontrib>Nicolae, Alexandru M.</creatorcontrib><creatorcontrib>Ravi, Ananth</creatorcontrib><title>Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions</title><title>Breast cancer research and treatment</title><addtitle>Breast Cancer Res Treat</addtitle><addtitle>Breast Cancer Res Treat</addtitle><description>Purpose
Magnetic Occult Lesion Localization Instrument (MOLLI) is a wireless, non-radioactive alternative for non-palpable breast lesion localization. The primary objective of this first-in-human study was to evaluate the clinical feasibility of using MOLLI for intraoperative localization of non-palpable breast lesions.
Methods
Twenty women with non-palpable breast lesions at a single institution received a lumpectomy using the MOLLI guidance system. Patients were co-localized with magnetic and radioactive markers up to 7 days before excision by a dedicated breast radiologist under sonographic guidance. Both markers were localized intraoperatively using dedicated hand-held probes. The primary outcome was successful excision of the magnetic marker, confirmed radiographically and pathologically. Demographic data, margin positivity, and re-excision rates were collected. Surgical oncologists, radiologists, and pathology staff were surveyed for user satisfaction.
Results
Post-radiological analysis:
Post-implant mammograms verified that 17/20 markers were placed directly in the lesion center. Radiologists reported that all marker implantations procedures were “easy” or “very easy” following a single training session.
Post-surgical analysis:
All MOLLI markers were successfully removed with the specimen during surgical excision. In all cases, surgeons ranked the MOLLI guidance system as “very easy” for lesion localization.
Pathologic analysis:
All patients had negative margins. All anatomic pathology staff ranked the MOLLI system as “very easy” to localize markers.
Conclusions
The MOLLI guidance system is a reliable and accurate method for intraoperative localization of non-palpable breast lesions. Further evaluation of the MOLLI system in studies against current standards of care is required to demonstrate system cost-effectiveness and improved patient-reported outcomes.</description><subject>Breast</subject><subject>Breast cancer</subject><subject>Cancer research</subject><subject>Clinical Trial</subject><subject>Lesions</subject><subject>Localization</subject><subject>Lumpectomy</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><issn>0167-6806</issn><issn>1573-7217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kt9qFDEUxgdR7Lr6Al5IwJsKTj2Zf5ncCKVYXZiyIHodspmTbUomWZOZYvdRfNpmd2trRSQMycz5fd-ZE74se03hhAKwD5FCXfEcaHrSgefbJ9mM1qzMWUHZ02wGtGF500JzlL2I8QoAOAP-PDsqKUuCms6yX18xTnaMxGsiyeZSRiSL98R5lwfpej-YLfYkjlN_Q_Ba2kmOxq0TeiHXDkejyFKpZEA6jMY70nklrdkmKr0sXBzDNKAbyfHFsusW74j2geBPZfZw6rlrtJF2I1cWySqgjCOxe6v4MnumpY346m6fZ9_PP307-5J3y8-Ls9MuV3VFx7xt20bqUmuse6hB86pnfQtU1S0oKgvNeI-t5JrzQjcaVNsUZaWAc9RAi7KcZx8PvptpNWCv0u8GacUmmEGGG-GlEY8rzlyKtb8WDeesSGbz7PjOIPgfE8ZRDCYqtFY69FMUxe66eQlsh779C73yU3BpvETVUBRQAX-g1tKiME771FftTMVpQ0valLyqE3XyDyqtHgejvENt0vdHguIgUMHHGFDfz0hB7BIlDokSKVFinyixTaI3f97OveR3hBJQHoCYSm6N4WGk_9jeApln2DE</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Look Hong, Nicole</creator><creator>Wright, Frances C.</creator><creator>Semple, Mark</creator><creator>Nicolae, Alexandru M.</creator><creator>Ravi, Ananth</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4583-5741</orcidid></search><sort><creationdate>20200201</creationdate><title>Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions</title><author>Look Hong, Nicole ; Wright, Frances C. ; Semple, Mark ; Nicolae, Alexandru M. ; Ravi, Ananth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-8886af3ffe5d050f94d7d801c580c1a2f79de8a9f992f6f0c86234c099ef01233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Breast</topic><topic>Breast cancer</topic><topic>Cancer research</topic><topic>Clinical Trial</topic><topic>Lesions</topic><topic>Localization</topic><topic>Lumpectomy</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Look Hong, Nicole</creatorcontrib><creatorcontrib>Wright, Frances C.</creatorcontrib><creatorcontrib>Semple, Mark</creatorcontrib><creatorcontrib>Nicolae, Alexandru M.</creatorcontrib><creatorcontrib>Ravi, Ananth</creatorcontrib><collection>SpringerOpen</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Breast cancer research and treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Look Hong, Nicole</au><au>Wright, Frances C.</au><au>Semple, Mark</au><au>Nicolae, Alexandru M.</au><au>Ravi, Ananth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions</atitle><jtitle>Breast cancer research and treatment</jtitle><stitle>Breast Cancer Res Treat</stitle><addtitle>Breast Cancer Res Treat</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>179</volume><issue>3</issue><spage>671</spage><epage>676</epage><pages>671-676</pages><issn>0167-6806</issn><eissn>1573-7217</eissn><abstract>Purpose
Magnetic Occult Lesion Localization Instrument (MOLLI) is a wireless, non-radioactive alternative for non-palpable breast lesion localization. The primary objective of this first-in-human study was to evaluate the clinical feasibility of using MOLLI for intraoperative localization of non-palpable breast lesions.
Methods
Twenty women with non-palpable breast lesions at a single institution received a lumpectomy using the MOLLI guidance system. Patients were co-localized with magnetic and radioactive markers up to 7 days before excision by a dedicated breast radiologist under sonographic guidance. Both markers were localized intraoperatively using dedicated hand-held probes. The primary outcome was successful excision of the magnetic marker, confirmed radiographically and pathologically. Demographic data, margin positivity, and re-excision rates were collected. Surgical oncologists, radiologists, and pathology staff were surveyed for user satisfaction.
Results
Post-radiological analysis:
Post-implant mammograms verified that 17/20 markers were placed directly in the lesion center. Radiologists reported that all marker implantations procedures were “easy” or “very easy” following a single training session.
Post-surgical analysis:
All MOLLI markers were successfully removed with the specimen during surgical excision. In all cases, surgeons ranked the MOLLI guidance system as “very easy” for lesion localization.
Pathologic analysis:
All patients had negative margins. All anatomic pathology staff ranked the MOLLI system as “very easy” to localize markers.
Conclusions
The MOLLI guidance system is a reliable and accurate method for intraoperative localization of non-palpable breast lesions. Further evaluation of the MOLLI system in studies against current standards of care is required to demonstrate system cost-effectiveness and improved patient-reported outcomes.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>31754951</pmid><doi>10.1007/s10549-019-05499-z</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-4583-5741</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0167-6806 |
ispartof | Breast cancer research and treatment, 2020-02, Vol.179 (3), p.671-676 |
issn | 0167-6806 1573-7217 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6997262 |
source | Springer Link |
subjects | Breast Breast cancer Cancer research Clinical Trial Lesions Localization Lumpectomy Medicine Medicine & Public Health Oncology |
title | Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T01%3A15%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Results%20of%20a%20phase%20I,%20non-randomized%20study%20evaluating%20a%20Magnetic%20Occult%20Lesion%20Localization%20Instrument%20(MOLLI)%20for%20excision%20of%20non-palpable%20breast%20lesions&rft.jtitle=Breast%20cancer%20research%20and%20treatment&rft.au=Look%20Hong,%20Nicole&rft.date=2020-02-01&rft.volume=179&rft.issue=3&rft.spage=671&rft.epage=676&rft.pages=671-676&rft.issn=0167-6806&rft.eissn=1573-7217&rft_id=info:doi/10.1007/s10549-019-05499-z&rft_dat=%3Cgale_pubme%3EA613163945%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c541t-8886af3ffe5d050f94d7d801c580c1a2f79de8a9f992f6f0c86234c099ef01233%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2350220409&rft_id=info:pmid/31754951&rft_galeid=A613163945&rfr_iscdi=true |